top of page

PHD Public Health and Epidemiology, Indian, Ayurvedic and Preventive Medicine, COVID-19

Updated: Jan 25

My central academic and professional focus has long been on public health and my dream of contributing to a better understanding of the epidemiological factors that account for the progression of the disease. My passion for this area of study has led me to this application process to study towards and earn the Ph.D.that we have been living through this year, which heightens my sense of urgency and timeliness in choosing a Degree in Epidemiology. My dedication to this field has been strengthened by the global pandemic we have been living through this year, which dramatically heightens my sense of urgency and timeliness in my lifelong career choice. This is especially true given that COVID-19 has hit India and the United States especially hard, the two countries I think of as home. Among Ph.D. programs in Public Health with a focus on Epidemiology, XXXX University is my first choice because I admire the rigor and breadth of the curriculum and the location of your program. My father practiced naturopathic medicine. I watched him care for his patients as I was growing up, and as I saw it, every hug and smile he gave showed me the value of being a physician. Thus, I followed in my father’s footsteps and earned the Bachelor of Ayurvedic Medicine and Surgery (B.A.M.S) in India. This ancient system of medicine utilizes herbs, diets, and specific health practices to treat acute and chronic illnesses. I learned the Ayurvedic principles and gained valuable insights into the findings of Ayurveda, which I see as of great relevance for the practice of preventive medicine. My internship that followed medical school trained me in both the procedures of modern and traditional Ayurvedic therapies, working with real-time emergency cases like trauma and poisoning—trained in basic emergency measures such as cardiopulmonary resuscitation, intubation, treatment of shock, suturing of the education and promulgating information concerning the relationship between infectious diseases and our genetic codes placed,s bandage techniques, hydration therapies, etc. I also worked at Satya Hospital, Warangal, as a trainee medical student on a part-time basis. I was supervised by consultant physicians who helped me gain practical exposure and develop my ability to diagnose diseases. While still in Medical School, I also learned SPSS and SAS to assist my community medicine professor with various projects funded by the Central Council of Indian Medicine. I became a clinical SAS programmer for Clinovo research labs, where I gained a solid understanding of US healthcare utilization databases. I constantly read journals in medicine and health to stay abreast with recent technological developments. I participated in all medical camps and health awareness programs sponsored by our college. As an NSS (National Service Scheme) volunteer, I participated in awareness rallies and immunization programs and educated people regarding sanitation measures, contraception, STDs, etc. The interaction with humble people in rural areas helped cultivate my compassion for my patients, most of whom were suffering from chronic, congenital, or infectious diseases; I worked to identify genes associated with the disease in question. I realized that education and promulgating information concerning the relationship between infectious diseases and our genetic codes place some at greater risk than others; programs could help encourage healthier lifestyle choices among the individuals in question. Thus, I began to engage with public health issues, bioinformatics, drug design, vaccine creation, health statistics, and disease surveillance.

Completing my MPH Degree at XXXX University (20XX) provided me with rigorous coursework, extensive field experience, a solid foundation in population health principles, epidemiological methods and biostatistics, and expertise in study design. I learned how to examine disease patterns, disease prevention, and wellness.

As a clinical statistician at Inventiv Health Clinical, I efficiently communicated real-world issues and strategies to all internal stakeholders. I worked on projects, applying and boosting traditional propensity scores to assess the risk of angioedema associated with angiotensin-converting, enzyme inhibitors, angiotensin receptor blockers, and beta-blockers using an extensive US health claims database. My research was presented at the International Society of Pharmacoepidemiology. Another study I worked on analyzed the risk factors of healthy volunteers using data captured for a Phase 1 clinical research unit. I played an essential role in constructing Sentinel, a novel visualization dashboard that displays patient journey maps of healthy volunteers. I was also most thankful for evaluating the FDA’s mini sentinel cohort identification tool - developed through the FDA’sSentinell initiative for application in active disease surveillance - by determining the incidence of hepatic decompensation, a clinical out. This clinical outcomevariousome that can occur in the natural history of the disease or during treatment of hepatitis C infection.

In my current role at XXXX Pharmaceuticals in City, State, I provide epidemiology expertise and mentorship, collaborating with agencies to design and implement epidemiological projects that project that epidemiological projects. I play a critical role in pharmacoepidemiology studies' design and implementation, satisfying post-marketing regulatory commitments. I perform an independent analysis of real-world data, including critical appraisal and in-depth scientific literature reviews provide. The data generated from these claims databases offers valuable insights into patient selection for clinical trials and highlights the importance of real-world evidence to support clinical trial design. I have also assisted in writing protocols, statistical analysis plans, and publishing scientific articles. For instance, I explored the incidence of venous thromboembolism in treated patients with rheumatoid arthritis. I spent a lot of time examining the biological or targeted synthetic disease-modifying antirheumatic drugs (DMARDs) in a real-world setting. This work was published in an RMD journal.

Early this year, I heard about the coronavirus pandemic while presenting an abstract at a conference on statistical practice in California. About 15 members of my extended family in India became infected with the virus during the same month. Everyone in my family was coping with great strain and anxiety, with the inundation of COVID-19 news a constant reminder of sadness and grief. I decided to give back to the community where I have my deepest roots and started volunteering under the direction of my community medicine professor, meeting virtually with district epidemiologists in India to build a COVID-19 dashboard that identifies hotspots in Warangal and surrounding areas. I also participated in various webinars to better understand the COVID-19 spread. In my current position at XXXX Pharmaceuticals, we use the Optum EHR database to understand the feasibility of a study in pursuingincidence of QT prolongation in hospitalized patients diagnosed with COVID-19. The desire and passion toPh.D.rsue a Ph.D. in Epidemiology and Public Health has been enhanced further by the pandemic, such a graphic demonstration of the need and urgency that exists, not just for the present but even more importantly for the future.

COVID-19 has helped sharpen my mind and made me more adept at handling critical and emergency issues. I look forward to furtherfurthering research on infectious diseases, howprogramsproject they affect large population programs, and the best ways to educate people on the best ways to avoid or prevent contagion or occurrence of the disease in question. I am also particularly interested in infections transmitted through blood, such as HIV and Hepatitis B. I have witnessed doctors becoming infected with dreadful diseases and deaths due to accidental needle pricks.

I hope to earn a Ph.D. in Epidemiology from XXXX University because it offers state-of-the-art facilities and ample research opportunities. I believe my solid foundation in medical terminology, thoroughgoing awareness of HIPAA guidelines, sound knowledge of computer applications for public health, and experience in dealing with public health issues help make me a strong candidate for your program.

I crave the rigors of your mainly distinguished program at XXXX University; I am confident that my skills, experience, and hardworking nature, driven forward by my intense sense of purpose, will enable me to excel if selected. I look forward to lifelong learning and research in Epidemiology and Public Health based on the foundation programs I will acquire in one of the leading Ph.D. Programs in Epidemiology in the world.

I thank you for considering my application.

#phd #epidemiology #statementofpurpose #samples #personal #writing #editing #service

  • WhatsApp Dr. Edinger
bottom of page